YMAB Message Board Post 10011778 | Y-mAbs Therapeutics Inc.
home / stock / ymab / ymab message board
racebrakesshop
(investorshub)
Posted on: Apr/02/2023 14:50:17
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171598533
$YMAB: WHAT?????
News, Short Squeeze, Breakout and More Instantly...
-
NEW YORK, July 01, 2024 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel radioimmunotherapy and antibody-based therapeutic pr...
-
Q1 2023 DANYELZA® record net product revenues of $20.3 million, driving YoY growth of 93% and a 24% sequential increase compared to Q4 2022 Management updates 2023 financial guidance, now anticipating higher DANYELZA net revenues of $80-85 million and lower cash burn of $40-50 millio...
-
NEW YORK, April 28, 2023 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) today announced that it will report its financial results for the quarter ended March 31, 2023, on Monday, May 8, 2023, after the close of the U.S. financi...